The Medwatch Industry Analysis 2013 is conducted by Medwatch with the contribution of Medico Insight+ (M3 Research and A&B Analyse), Sydbank, Dansk Aktie Analyse and Novo A/S. It includes:
- Analyses of public life science companies from Denmark and abroad for the current year
- An extensive survey of patient attitudes to their treatment within a long line of disease areas
- The most important events in the global life science industry in 2013
- Key figures from the most recent financial reports from the biggest Danish life science companies
At the morning conference, the main conclusions from the report will be presented and a printed version of the actual report will be given to the participants.
Program:
7.45-8.00: Introduction to The Medwatch Industry Analysis 2013 by editor Henrik Tüchsen, Medwatch.
8.00-8.45: Medico Insight+ presents its major patient survey and a smaller population survey.
8.45-9.15: Time to meet colleagues from the industry and journalists from Medwatch.
We serve coffee, fruit and pastries.
Time and place: Friday November 15 in the meeting hall in JP/Politikens Hus, Rådhuspladsen 37, Copenhagen.Entrance from Vestergade 30, Copenhagen.
Price: DKK 495 per person* (Free to attend for Medwatch Plus subscribers)
Signing up: Send an e-mail to medwatch@medwatch.dk
More info about Medwatch Plus: 70777441 – medwatch@infowatch.dk
* No-shows are charged a fee of DKK 495
(Please note that all presentations are in Danish)
Mere fra MedWatch
Storbritannien køber 20.000 koppevacciner hos Bavarian
Storbritannien oplyser nu, at landet køber vacciner mod kopper fra danske Bavarian Nordic.
Bavarian Nordic vil have godkendt vaccine til brug mod abekopper i Europa
Bavarian Nordics koppevaccine Junneos er ikke godkendt til brug mod abekopper i Europa. Det har dog ikke stoppet flere lande fra at købe den til formålet alligevel. Står det til Bavarian Nordic og finansdirektør Henrik Juuel, planlægger man at få den godkendt.
Medie: Spanien vil købe Barvarians koppevaccine
Spanien er klar til at købe Bavarians koppevaccine Imanex, der i USA og Canada markedsføres mod abekopper.
Bestyrelsesmedlem i Scandion Oncology stopper med øjeblikkelig virkning
Bestyrelsesmedlem i biotekselskabet Scandion Oncology træder ned fra sin post. En ny direktørstilling tager for meget tid, lyder det.
Overlæge finder dansk vaccinetilbud forsvarligt selv om godkendelse mangler
Fredag ankommer de første 200 doser af Bavarian Nordics koppevaccine til Danmark.
Kemiker til Incoming Materials i QC-afdeling 
Biomarker Operations Lead 
Scientific Writer 
Industrial Designer- Design Engineer 
Director Global Engineering 
(Senior) Drug Substance Specialist 
Senior QA Specialist 
Senior Chemical Safety Advisor 
Clinical Trial Manager for development of in vitro diagnostics 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Nordic Medical Affairs Manager 
GoGift is looking for a Global Legal Manager 
Team Manager 
Regnskabschef 
Boligchef til solid lokalbank i vækst 
Er du 100-metermester i at arbejde med de finansielle markeder og instrumenter? Asset Services Specialist søges!